Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drazer

Showing results (71-80 of 101) with videos related to

Pageof 11
Sort By:
Cancer|April 12, 2023
Surgical phenotype of patients with peritoneal mesothelioma and a germline mutationYaniv Berger, Meghana Gadiraju, Ankit Dhiman, et al.
Leukemia & Lymphoma|March 5, 2024
Treatment outcomes of venetoclax-combination regimens for relapsed/refractory myeloid malignancies after anti-CD47-directed therapyRafael Madero-Marroquin, Emily Dworkin, Howard Weiner, et al.
Annals of Surgical Oncology|February 19, 2024
Venous Thromboembolism in Peritoneal Mesothelioma: Uncovering the Hidden RiskVarun V Bansal, Owen Mitchell, Celyn Bregio, et al.
Ejhaem|June 16, 2025
Outcomes for Patients With Myeloid Neoplasms Treated With Chemotherapy Plus Venetoclax After Prior Venetoclax TherapyRafael Madero-Marroquin, Joseph Cannova, Emily Dworkin, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 8, 2026
Germline genetic testing and privacy concerns in patients with mesotheliomaOwen D Mitchell, Abigail P Sneider, Katie Gilliam, et al.
British Journal of Haematology|October 27, 2025
Outcomes of patients with relapsed/refractory acute leukaemia treated with revumenib with a focus on post-revumenib therapiesMiles Thomas, Hannah Johnston, Emily Dworkin, et al.
Molecular Cancer Therapeutics|March 4, 2026
Targeting menin in T-lineage acute lymphoblastic leukemiaKathryn Shimamoto, Diren Arda Karaoglu, Olivia Arnold, et al.
Blood Advances|December 1, 2023
Socioeconomic determinants of the biology and outcomes of acute lymphoblastic leukemia in adultsHannah Johnston, Hamed Rahmani Youshanlouei, Clinton Osei, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 16, 2026
The International Association for the Study of Lung Cancer Pleural Mesothelioma Staging Project: Impact of Common Molecular Alterations and PD-L1 Expression on Overall Survival in a Select Cohort from the IASLC 9<sup>th</sup> Edition Staging DatabaseSoo-Ryum Yang, Melissa Y Tjota, Emily Goren, et al.
Leukemia|May 7, 2025
Predisposition to hematopoietic malignancies by deleterious germline CHEK2 variantsRyan J Stubbins, Stephen Arnovitz, Jennie Vagher, et al.
Pageof 11

Showing results (71-80 of 101) with videos related to

Sort By:
Pageof 11
Cancer|April 12, 2023
Surgical phenotype of patients with peritoneal mesothelioma and a germline mutationYaniv Berger, Meghana Gadiraju, Ankit Dhiman, et al.
Leukemia & Lymphoma|March 5, 2024
Treatment outcomes of venetoclax-combination regimens for relapsed/refractory myeloid malignancies after anti-CD47-directed therapyRafael Madero-Marroquin, Emily Dworkin, Howard Weiner, et al.
Annals of Surgical Oncology|February 19, 2024
Venous Thromboembolism in Peritoneal Mesothelioma: Uncovering the Hidden RiskVarun V Bansal, Owen Mitchell, Celyn Bregio, et al.
Ejhaem|June 16, 2025
Outcomes for Patients With Myeloid Neoplasms Treated With Chemotherapy Plus Venetoclax After Prior Venetoclax TherapyRafael Madero-Marroquin, Joseph Cannova, Emily Dworkin, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 8, 2026
Germline genetic testing and privacy concerns in patients with mesotheliomaOwen D Mitchell, Abigail P Sneider, Katie Gilliam, et al.
British Journal of Haematology|October 27, 2025
Outcomes of patients with relapsed/refractory acute leukaemia treated with revumenib with a focus on post-revumenib therapiesMiles Thomas, Hannah Johnston, Emily Dworkin, et al.
Molecular Cancer Therapeutics|March 4, 2026
Targeting menin in T-lineage acute lymphoblastic leukemiaKathryn Shimamoto, Diren Arda Karaoglu, Olivia Arnold, et al.
Blood Advances|December 1, 2023
Socioeconomic determinants of the biology and outcomes of acute lymphoblastic leukemia in adultsHannah Johnston, Hamed Rahmani Youshanlouei, Clinton Osei, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 16, 2026
The International Association for the Study of Lung Cancer Pleural Mesothelioma Staging Project: Impact of Common Molecular Alterations and PD-L1 Expression on Overall Survival in a Select Cohort from the IASLC 9<sup>th</sup> Edition Staging DatabaseSoo-Ryum Yang, Melissa Y Tjota, Emily Goren, et al.
Leukemia|May 7, 2025
Predisposition to hematopoietic malignancies by deleterious germline CHEK2 variantsRyan J Stubbins, Stephen Arnovitz, Jennie Vagher, et al.
Pageof 11